1. Home
  2. DYAI vs EQS Comparison

DYAI vs EQS Comparison

Compare DYAI & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYAI
  • EQS
  • Stock Information
  • Founded
  • DYAI 1979
  • EQS 1991
  • Country
  • DYAI United States
  • EQS United States
  • Employees
  • DYAI N/A
  • EQS N/A
  • Industry
  • DYAI Biotechnology: Biological Products (No Diagnostic Substances)
  • EQS Finance Companies
  • Sector
  • DYAI Health Care
  • EQS Finance
  • Exchange
  • DYAI Nasdaq
  • EQS Nasdaq
  • Market Cap
  • DYAI 30.2M
  • EQS 33.7M
  • IPO Year
  • DYAI 2004
  • EQS N/A
  • Fundamental
  • Price
  • DYAI $1.13
  • EQS $1.83
  • Analyst Decision
  • DYAI Strong Buy
  • EQS
  • Analyst Count
  • DYAI 2
  • EQS 0
  • Target Price
  • DYAI $4.50
  • EQS N/A
  • AVG Volume (30 Days)
  • DYAI 105.9K
  • EQS 14.0K
  • Earning Date
  • DYAI 11-10-2025
  • EQS 01-01-0001
  • Dividend Yield
  • DYAI N/A
  • EQS N/A
  • EPS Growth
  • DYAI N/A
  • EQS N/A
  • EPS
  • DYAI N/A
  • EQS N/A
  • Revenue
  • DYAI $4,135,078.00
  • EQS $1,355,000.00
  • Revenue This Year
  • DYAI $34.23
  • EQS N/A
  • Revenue Next Year
  • DYAI $19.57
  • EQS N/A
  • P/E Ratio
  • DYAI N/A
  • EQS N/A
  • Revenue Growth
  • DYAI 129.20
  • EQS 60.35
  • 52 Week Low
  • DYAI $0.71
  • EQS $0.74
  • 52 Week High
  • DYAI $2.20
  • EQS $2.49
  • Technical
  • Relative Strength Index (RSI)
  • DYAI 52.71
  • EQS 37.01
  • Support Level
  • DYAI $1.10
  • EQS $1.82
  • Resistance Level
  • DYAI $1.27
  • EQS $1.99
  • Average True Range (ATR)
  • DYAI 0.11
  • EQS 0.10
  • MACD
  • DYAI 0.00
  • EQS -0.04
  • Stochastic Oscillator
  • DYAI 44.84
  • EQS 14.81

About DYAI Dyadic International Inc.

Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

About EQS Equus Total Return Inc.

Equus Total Return Inc is a United States-based closed-end management investment company. It invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.

Share on Social Networks: